Christine Lykke Thoustrup
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Christine Lykke Thoustrup has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
- Linea Pretzmann
Child and Adolescent Mental Health Center, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Postal address: Gentofte Hospitalsvej 3A, Hellerup, Copenhagen, 2900, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Postal address: Blegdamsvej 3B, 33.5, Sektion A, København N, Copenhagen, 2200, Denmark
6 shared publications - Nicole Nadine Lønfeldt
Child and Adolescent Mental Health Center Mental Health Services CPH Copenhagen University Hospital Denmark
6 shared publications - Anne Katrine Pagsberg
Child and Adolescent Mental Health Center Copenhagen University Hospital – Bispebjerg and Frederiksberg Copenhagen Denmark
5 shared publications - Julie Hagstrøm
Child and Adolescent Mental Health Center Copenhagen University Hospital – Mental Health Services CPH Copenhagen Denmark
5 shared publications - Kerstin Jessica Plessen
Division of Child and Adolescent Psychiatry Department of Psychiatry Lausanne University Hospital and University of Lausanne Lausanne Switzerland
5 shared publications - Melanie Ritter
Child and Adolescent Mental Health Center, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Postal address: Gentofte Hospitalsvej 3A, Hellerup, Copenhagen, 2900, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Postal address: Blegdamsvej 3B, 33.5, Sektion A, København N, Copenhagen, 2200, Denmark
5 shared publications
Latest Publications
- Open Access
- 22 September 2026
- Published by Elsevier in Journal of Anxiety Disorders
- Vol. 123, 103235
Neurocognitive correlates of psychotherapeutic treatment response in pediatric obsessive-compulsive disorder: Results from the TECTO trial
- 22 September 2026
- Published by Elsevier in Journal of Anxiety Disorders
- Vol. 123, 103235
Open AccessNeurocognitive correlates of psychotherapeutic treatment response in pediatric obsessive-compulsive disorder: Results from the TECTO trial
- 21 August 2026
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 35 (12) , 4051-4069
Clinical practices in ADHD management across Europe: findings from the ESCAP research academy survey
In several European countries, national clinical guidelines for the management of ADHD are lacking. In others, guidelines are outdated or do not address more detailed aspects of care, such as medication titration procedures or specific recommendations for school adjustments. Perceptions of the appropriateness of treatment, which influence the delivery of care for ADHD, are shaped by sociocultural aspects. Consequently, practices in the management of ADHD are expected to substantially vary across Europe. To better understand current practices in both pharmacological and non-pharmacological management of ADHD, as well as clinicians’ perceptions of treatment appropriateness, we conducted an online survey among European qualified child and adolescent (neuro)psychiatrists and general psychiatrists or trainees involved in the care of children and adolescents with ADHD. The survey was developed and implemented by the European Society for Child and Adolescent Psychiatry (ESCAP) Research Academy, with input from the European ADHD Guidelines Group (EAGG). It was completed by 1,441 clinicians of varying seniority from 23 European countries. The findings provide updated insights into ADHD management across Europe and highlight three key unmet needs. First, several clinically relevant areas lack sufficient evidence, including how to personalise treatment and identify practical predictors of treatment response. Second, some existing evidence has not yet been adequately translated into clinical guidelines or routine practice, particularly regarding comparative treatment effects and dose–response relationships relevant to medication titration. Third, some respondents reported needs that are already addressed in existing international guidelines, suggesting that language barriers may limit access to guidance and underscoring the importance of developing country-specific recommendations in local languages. Overall, this survey - to our knowledge the largest of its kind conducted in Europe - provides valuable information to inform future clinical guidelines, research priorities, and health policy. It also informs future training programmes aimed at reducing bias in the perception and delivery of ADHD treatment.
- 21 August 2026
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 35 (12) , 4051-4069
Clinical practices in ADHD management across Europe: findings from the ESCAP research academy survey
In several European countries, national clinical guidelines for the management of ADHD are lacking. In others, guidelines are outdated or do not address more detailed aspects of care, such as medication titration procedures or specific recommendations for school adjustments. Perceptions of the appropriateness of treatment, which influence the delivery of care for ADHD, are shaped by sociocultural aspects. Consequently, practices in the management of ADHD are expected to substantially vary across Europe. To better understand current practices in both pharmacological and non-pharmacological management of ADHD, as well as clinicians’ perceptions of treatment appropriateness, we conducted an online survey among European qualified child and adolescent (neuro)psychiatrists and general psychiatrists or trainees involved in the care of children and adolescents with ADHD. The survey was developed and implemented by the European Society for Child and Adolescent Psychiatry (ESCAP) Research Academy, with input from the European ADHD Guidelines Group (EAGG). It was completed by 1,441 clinicians of varying seniority from 23 European countries. The findings provide updated insights into ADHD management across Europe and highlight three key unmet needs. First, several clinically relevant areas lack sufficient evidence, including how to personalise treatment and identify practical predictors of treatment response. Second, some existing evidence has not yet been adequately translated into clinical guidelines or routine practice, particularly regarding comparative treatment effects and dose–response relationships relevant to medication titration. Third, some respondents reported needs that are already addressed in existing international guidelines, suggesting that language barriers may limit access to guidance and underscoring the importance of developing country-specific recommendations in local languages. Overall, this survey - to our knowledge the largest of its kind conducted in Europe - provides valuable information to inform future clinical guidelines, research priorities, and health policy. It also informs future training programmes aimed at reducing bias in the perception and delivery of ADHD treatment.
- Open Access
- 18 August 2026
- Published by Elsevier in Journal of Obsessive-Compulsive and Related Disorders
- Vol. 50
Emotion regulation difficulties in pediatric obsessive-compulsive disorder: A modifiable treatment target
- 18 August 2026
- Published by Elsevier in Journal of Obsessive-Compulsive and Related Disorders
- Vol. 50
Open AccessEmotion regulation difficulties in pediatric obsessive-compulsive disorder: A modifiable treatment target
- 14 March 2025
- Published by Elsevier in Journal of Anxiety Disorders
- Vol. 111, 103002
Emotion regulation difficulties in children and adolescents with obsessive-compulsive disorder: A multi-informant and multi-method study
- 14 March 2025
- Published by Elsevier in Journal of Anxiety Disorders
- Vol. 111, 103002
Emotion regulation difficulties in children and adolescents with obsessive-compulsive disorder: A multi-informant and multi-method study
- 3 March 2025
- Published by Elsevier in Journal of Anxiety Disorders
- Vol. 111, 102996
Computationally derived parent-child interaction patterns and oxytocin in children with and without OCD
- 3 March 2025
- Published by Elsevier in Journal of Anxiety Disorders
- Vol. 111, 102996
Computationally derived parent-child interaction patterns and oxytocin in children with and without OCD
- Open Access
- 4 December 2024
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 43, 101408
Emotion dysregulation in youths with obsessive-compulsive disorder and its implication for treatment - An exploratory study from the TECTO trial: A protocol and statistical analysis plan
- 4 December 2024
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 43, 101408
Open AccessEmotion dysregulation in youths with obsessive-compulsive disorder and its implication for treatment - An exploratory study from the TECTO trial: A protocol and statistical analysis plan
- Open Access
- 1 January 2024
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Child and Adolescent Psychiatry and Psychology
- Vol. 12 (1) , 20240014
Normative reference interval for youths on the Difficulties in Emotion Regulation Scale (DERS)
Background: The Difficulties in Emotion Regulation Scale (DERS) is widely used in both clinical and non-clinical research to assess emotional regulation difficulties. To guide interpretation of scores, establishing thresholds for normative DERS scores is informative. However, despite its widespread use, to date no study has provided such threshold for youths. This literature review aimed to fill this gap by examining the 90% reference interval for the DERS in youths aged 11–19 years. Methods: We conducted a systematic search on PubMed (MEDLINE) on 12 March 2024, to identify studies reporting DERS-36 total scores (DERS-T) in youths aged 11–19 years from either community-based populations or healthy volunteers. Results: A total of 34 studies were included; 20 studies included community-based participants (n = 6,960), while the remaining 14 studies included healthy volunteers (n = 766), resulting in a total of 7,726 participants. The 90% reference interval for DERS-T from all included participants had a threshold of 121.8 normative emotion regulation in youths. Conclusion and significance: This threshold is considerably higher than DERS-T scores reported in most clinical studies and a substantial variation in reference intervals across studies is observed. We identify five main methodological factors related to the DERS-36 and discuss their potential impact on the validity, reliability, and generalizability of findings. Given the DERS-T range of 36–180, we conclude that the 90% reference interval derived from our review is not sufficiently robust to guide clinical or scientific interpretations. Our work is not exhaustive, and further research is needed to validate and test the reliability of this reference interval.
- 1 January 2024
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Child and Adolescent Psychiatry and Psychology
- Vol. 12 (1) , 20240014
Open AccessNormative reference interval for youths on the Difficulties in Emotion Regulation Scale (DERS)
Background: The Difficulties in Emotion Regulation Scale (DERS) is widely used in both clinical and non-clinical research to assess emotional regulation difficulties. To guide interpretation of scores, establishing thresholds for normative DERS scores is informative. However, despite its widespread use, to date no study has provided such threshold for youths. This literature review aimed to fill this gap by examining the 90% reference interval for the DERS in youths aged 11–19 years. Methods: We conducted a systematic search on PubMed (MEDLINE) on 12 March 2024, to identify studies reporting DERS-36 total scores (DERS-T) in youths aged 11–19 years from either community-based populations or healthy volunteers. Results: A total of 34 studies were included; 20 studies included community-based participants (n = 6,960), while the remaining 14 studies included healthy volunteers (n = 766), resulting in a total of 7,726 participants. The 90% reference interval for DERS-T from all included participants had a threshold of 121.8 normative emotion regulation in youths. Conclusion and significance: This threshold is considerably higher than DERS-T scores reported in most clinical studies and a substantial variation in reference intervals across studies is observed. We identify five main methodological factors related to the DERS-36 and discuss their potential impact on the validity, reliability, and generalizability of findings. Given the DERS-T range of 36–180, we conclude that the 90% reference interval derived from our review is not sufficiently robust to guide clinical or scientific interpretations. Our work is not exhaustive, and further research is needed to validate and test the reliability of this reference interval.
- Open Access
- 20 June 2023
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 34, 101173
Adverse events in cognitive behavioral therapy and relaxation training for children and adolescents with obsessive-compulsive disorder: A mixed methods study and analysis plan for the TECTO trial
- 20 June 2023
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 34, 101173
Open AccessAdverse events in cognitive behavioral therapy and relaxation training for children and adolescents with obsessive-compulsive disorder: A mixed methods study and analysis plan for the TECTO trial
- Open Access
- 28 October 2022
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 11 (10) , e39613
Associations Between the Severity of Obsessive-Compulsive Disorder and Vocal Features in Children and Adolescents: Protocol for a Statistical and Machine Learning Analysis
Background: Artificial intelligence tools have the potential to objectively identify youth in need of mental health care. Speech signals have shown promise as a source for predicting various psychiatric conditions and transdiagnostic symptoms. Objective: We designed a study testing the association between obsessive-compulsive disorder (OCD) diagnosis and symptom severity on vocal features in children and adolescents. Here, we present an analysis plan and statistical report for the study to document our a priori hypotheses and increase the robustness of the findings of our planned study. Methods: Audio recordings of clinical interviews of 47 children and adolescents with OCD and 17 children and adolescents without a psychiatric diagnosis will be analyzed. Youths were between 8 and 17 years old. We will test the effect of OCD diagnosis on computationally derived scores of vocal activation using ANOVA. To test the effect of OCD severity classifications on the same computationally derived vocal scores, we will perform a logistic regression. Finally, we will attempt to create an improved indicator of OCD severity by refining the model with more relevant labels. Models will be adjusted for age and gender. Model validation strategies are outlined. Results: Simulated results are presented. The actual results using real data will be presented in future publications. Conclusions: A major strength of this study is that we will include age and gender in our models to increase classification accuracy. A major challenge is the suboptimal quality of the audio recordings, which are representative of in-the-wild data and a large body of recordings collected during other clinical trials. This preregistered analysis plan and statistical report will increase the validity of the interpretations of the upcoming results. International Registered Report Identifier (IRRID): DERR1-10.2196/39613
- 28 October 2022
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 11 (10) , e39613
Open AccessAssociations Between the Severity of Obsessive-Compulsive Disorder and Vocal Features in Children and Adolescents: Protocol for a Statistical and Machine Learning Analysis
Background: Artificial intelligence tools have the potential to objectively identify youth in need of mental health care. Speech signals have shown promise as a source for predicting various psychiatric conditions and transdiagnostic symptoms. Objective: We designed a study testing the association between obsessive-compulsive disorder (OCD) diagnosis and symptom severity on vocal features in children and adolescents. Here, we present an analysis plan and statistical report for the study to document our a priori hypotheses and increase the robustness of the findings of our planned study. Methods: Audio recordings of clinical interviews of 47 children and adolescents with OCD and 17 children and adolescents without a psychiatric diagnosis will be analyzed. Youths were between 8 and 17 years old. We will test the effect of OCD diagnosis on computationally derived scores of vocal activation using ANOVA. To test the effect of OCD severity classifications on the same computationally derived vocal scores, we will perform a logistic regression. Finally, we will attempt to create an improved indicator of OCD severity by refining the model with more relevant labels. Models will be adjusted for age and gender. Model validation strategies are outlined. Results: Simulated results are presented. The actual results using real data will be presented in future publications. Conclusions: A major strength of this study is that we will include age and gender in our models to increase classification accuracy. A major challenge is the suboptimal quality of the audio recordings, which are representative of in-the-wild data and a large body of recordings collected during other clinical trials. This preregistered analysis plan and statistical report will increase the validity of the interpretations of the upcoming results. International Registered Report Identifier (IRRID): DERR1-10.2196/39613
- Open Access
- 19 March 2022
- Published by Springer Nature in BMC Psychiatry
- Vol. 22 (1) , 1-15
Family-based cognitive behavioural therapy versus family-based relaxation therapy for obsessive-compulsive disorder in children and adolescents: protocol for a randomised clinical trial (the TECTO trial)
Background: Cognitive behavioural therapy (CBT) is the recommended first-line treatment for children and adolescents with obsessive-compulsive disorder (OCD), but evidence concerning treatment-specific benefits and harms compared with other interventions is limited. Furthermore, high risk-of-bias in most trials prevent firm conclusions regarding the efficacy of CBT. We investigate the benefits and harms of family-based CBT (FCBT) versus family-based psychoeducation and relaxation training (FPRT) in youth with OCD in a trial designed to reduce risk-of-bias. Methods: This is an investigator-initiated, independently funded, single-centre, parallel group superiority randomised clinical trial (RCT). Outcome assessors, data managers, statisticians, and conclusion drawers are blinded. From child and adolescent mental health services we include patients aged 8–17 years with a primary OCD diagnosis and an entry score of ≥16 on the Children’s Yale-Brown Obsessive-Compulsive Scale (CY-BOCS). We exclude patients with comorbid illness contraindicating trial participation; intelligence quotient < 70; or treatment with CBT, PRT, antidepressant or antipsychotic medication within the last 6 months prior to trial entry. Participants are randomised 1:1 to the experimental intervention (FCBT) versus the control intervention (FPRT) each consisting of 14 75-min sessions. All therapists deliver both interventions. Follow-up assessments occur in week 4, 8 and 16 (end-of-treatment). The primary outcome is OCD symptom severity assessed with CY-BOCS at end-of-trial. Secondary outcomes are quality-of-life and adverse events. Based on sample size estimation, a minimum of 128 participants (64 in each intervention group) are included. Discussion: In our trial design we aim to reduce risk-of-bias, enhance generalisability, and broaden the outcome measures by: 1) conducting an investigator-initiated, independently funded RCT; 2) blinding investigators; 3) investigating a representative sample of OCD patients; 3) using an active control intervention (FPRT) to tease apart general and specific therapy effects; 4) using equal dosing of interventions and therapist supervision in both intervention groups; 5) having therapists perform both interventions decided by randomisation; 6) rating fidelity of both interventions; 7) assessing a broad range of benefits and harms with repeated measures. The primary study limitations are the risk of missing data and the inability to blind participants and therapists to the intervention. Trial registration: ClinicalTrials.gov: NCT03595098, registered July 23, 2018.
- 19 March 2022
- Published by Springer Nature in BMC Psychiatry
- Vol. 22 (1) , 1-15
Open AccessFamily-based cognitive behavioural therapy versus family-based relaxation therapy for obsessive-compulsive disorder in children and adolescents: protocol for a randomised clinical trial (the TECTO trial)
Background: Cognitive behavioural therapy (CBT) is the recommended first-line treatment for children and adolescents with obsessive-compulsive disorder (OCD), but evidence concerning treatment-specific benefits and harms compared with other interventions is limited. Furthermore, high risk-of-bias in most trials prevent firm conclusions regarding the efficacy of CBT. We investigate the benefits and harms of family-based CBT (FCBT) versus family-based psychoeducation and relaxation training (FPRT) in youth with OCD in a trial designed to reduce risk-of-bias. Methods: This is an investigator-initiated, independently funded, single-centre, parallel group superiority randomised clinical trial (RCT). Outcome assessors, data managers, statisticians, and conclusion drawers are blinded. From child and adolescent mental health services we include patients aged 8–17 years with a primary OCD diagnosis and an entry score of ≥16 on the Children’s Yale-Brown Obsessive-Compulsive Scale (CY-BOCS). We exclude patients with comorbid illness contraindicating trial participation; intelligence quotient < 70; or treatment with CBT, PRT, antidepressant or antipsychotic medication within the last 6 months prior to trial entry. Participants are randomised 1:1 to the experimental intervention (FCBT) versus the control intervention (FPRT) each consisting of 14 75-min sessions. All therapists deliver both interventions. Follow-up assessments occur in week 4, 8 and 16 (end-of-treatment). The primary outcome is OCD symptom severity assessed with CY-BOCS at end-of-trial. Secondary outcomes are quality-of-life and adverse events. Based on sample size estimation, a minimum of 128 participants (64 in each intervention group) are included. Discussion: In our trial design we aim to reduce risk-of-bias, enhance generalisability, and broaden the outcome measures by: 1) conducting an investigator-initiated, independently funded RCT; 2) blinding investigators; 3) investigating a representative sample of OCD patients; 3) using an active control intervention (FPRT) to tease apart general and specific therapy effects; 4) using equal dosing of interventions and therapist supervision in both intervention groups; 5) having therapists perform both interventions decided by randomisation; 6) rating fidelity of both interventions; 7) assessing a broad range of benefits and harms with repeated measures. The primary study limitations are the risk of missing data and the inability to blind participants and therapists to the intervention. Trial registration: ClinicalTrials.gov: NCT03595098, registered July 23, 2018.